Impact of a Prognostic 40-Gene Expression Profiling Test on Clinical Management Decisions for High-Risk Cutaneous Squamous Cell Carcinoma. (2020). SKIN The Journal of Cutaneous Medicine, 4(5), s64. https://doi.org/10.25251/skin.4.supp.63